COMMUNIQUÉS West-GlobeNewswire

Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals

02/08/2017 - 13:00

Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals Series C financing to fund Phase II clinical trials of APX001, a novel antifungal agent to treat life-threatening invasive [...]

Invivoscribe® lance le test de mutation LeukoStrat® CDx FLT3 sous forme de kit d'essai DVI labellisé CE

02/08/2017 - 10:50

SAN DIEGO, le 2 er août 2017 (GLOBE NEWSWIRE) - Invivoscribe ® Technologies Inc., une société internationale ayant de nombreuses années d'expérience en matière de solutions de test de clonalité et de biomarqueurs dans [...]

Eckert & Ziegler BEBIG : First Half-Year Results 2017 Published

02/08/2017 - 07:45

Seneffe - Belgium, August 2, 2017, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) has announced today its half-year results 2017. The report including a selection of consolidated key [...]

Eckert & Ziegler BEBIG : Publication du résultat du premier semestre 2017

02/08/2017 - 07:45

Seneffe - Belgique, 2 août 2017, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) a communiqué aujourd'hui son rapport du 1er semestre 2017. Le rapport qui comprend une sélection de [...]

DBV Technologies annonce le lancement d'EPITOPE, étude clinique de phase III d'évaluation de Viaskin Peanut dans le traitement des enfants de 1 à 3 ans atteints d'allergie à l'arachide

02/08/2017 - 07:30

Communiqué de presse Montrouge, France, le 2 août 2017 (7H30 CEST) DBV Technologies annonce le lancement d'EPITOPE, étude clinique de phase III d'évaluation de Viaskin Peanut dans le traitement des enfants de 1 à 3 ans [...]

DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age

02/08/2017 - 07:30

Press Release Montrouge, France,August 2, 2017 DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age Expansion of clinical program into younger children [...]

MDxHealth to Participate in Canaccord Genuity Growth Conference

02/08/2017 - 07:00

COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 2, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it will participate in the 37th [...]

MDxHealth participera à la Conférence Canaccord Genuity Growth

02/08/2017 - 07:00

ANNONCE D'ENTERPRISE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, le 2 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui sa participation à la [...]

Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States

01/08/2017 - 22:42

Company announcement - No. 29/2017 Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States Zealand Pharma A/S has today commenced an initial public offering of American [...]

Prothena to Report Second Quarter 2017 Financial Results on August 8

01/08/2017 - 22:05

DUBLIN, Ireland, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017

01/08/2017 - 22:05

GAITHERSBURG, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday [...]

NICOX : Nombre total de droits de vote au 31 juillet 2017

01/08/2017 - 17:45

Nicox SA Société anonyme au capital de 25 669 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 er août 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]

VALNEVA renforce son équipe dirigeante et nomme de nouveaux membres à son directoire pour soutenir sa croissance future

01/08/2017 - 17:45

Valneva renforce son équipe dirigeante et nomme de nouveaux membres à son directoire pour soutenir sa croissance future Nomination de David Lawrence comme Directeur Financier Nomination de Wolfgang Bender, MD/PhD, comme [...]

VALNEVA Announces Expansion of its Management Board - Strengthening Senior Management for Future Growth

01/08/2017 - 17:45

Valneva Announces Expansion of its Management Board - Strengthening Senior Management for Future Growth Appointment of David Lawrence as Chief Financial Officer (CFO) Appointment of Wolfgang Bender, MD/PhD as Chief [...]

Oriola Corporation - Repurchase of own shares on 1 August 2017

01/08/2017 - 17:45

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 1 August 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 1 August 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 13 188 Average price/share, EUR 3,623 [...]

NICOX : Number of voting rights as of July 31. 2017

01/08/2017 - 17:44

Nicox SA Société anonyme with a registered capital of € 25,669,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On August 1, 2017, MONTHLY PUBLICATION OF THE [...]

FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization

01/08/2017 - 16:00

Data from Landmark Trial Published in the Journal of the American Heart Association DUBLIN - August 1, 2017 - A n ew health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT [...]

CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research

01/08/2017 - 14:00

SANTA CLARA, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]

CrownBio lance des modèles innovants de maladies inflammatoires pour faire progresser la recherche préclinique

01/08/2017 - 14:00

SANTA CLARA, Californie, le 1 er août 2017 (GLOBE NEWSWIRE) - Crown Bioscience, filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]